| 2023 |
Wong, Y. Y., Harbison, J. E., Hope, C. M., Gundsambuu, B., Brown, K. A., Wong, S. W., . . . Barry, S. C. (2023). Parallel recovery of chromatin accessibility and gene expression dynamics from frozen human regulatory T cells. Scientific reports, 13(1), 5506-1-5506-15.
DOI Scopus8 WoS8 Europe PMC11 |
| 2020 |
Brown, C. Y., Sadlon, T., Hope, C. M., Wong, Y. Y., Wong, S., Liu, N., . . . Barry, S. C. (2020). Molecular Insights Into Regulatory T-Cell Adaptation to Self, Environment, and Host Tissues: Plasticity or Loss of Function in Autoimmune Disease. Frontiers in Immunology, 11(September), 1-17.
DOI Scopus15 WoS16 Europe PMC14 |
| 2019 |
Hope, C. M., Welch, J., Mohandas, A., Pederson, S., Hill, D., Gundsambuu, B., . . . Barry, S. C. (2019). Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes. European Journal of Immunology, 49(8), 1235-1250.
DOI Scopus21 WoS21 Europe PMC21 |
| 2018 |
Penington, J. S., Penno, M., Ngui, K., Ajami, N., Roth-Schulze, A., Wilcox, S., . . . Giles, L. (2018). Influence of fecal collection conditions and 16S rRNA gene sequencing protocols at two centers on human gut microbiota analysis. Scientific Reports, 8, 10 pages.
DOI |
| 2018 |
Sadlon, T., Brown, C. Y., Bandara, V., Hope, C. M., Schjenken, J. E., Pederson, S. M., . . . Barry, S. C. (2018). Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease. Clinical and Translational Immunology, 7(2), e1011-1-e1011-15.
DOI Scopus27 WoS23 Europe PMC21 |
| 2018 |
Penington, J., Penno, M., Ngui, K., Ajami, N., Roth-Schulze, A., Wilcox, S., . . . Vuillermin, P. (2018). Influence of fecal collection conditions and 16S rRNA gene sequencing at two centers on human gut microbiota analysis. Scientific Reports, 8(1), 4386-1-4386-10.
DOI Scopus45 WoS44 Europe PMC41 |
| 2018 |
Brown, C. Y., Dayan, S., Wong, S. W., Kaczmarek, A. K., Hope, C. M., Pederson, S. M., . . . Barry, S. C. (2018). FOXP3 and miR-155 cooperate to control the invasive potential of human breast cancer cells by down regulating ZEB2 independently of ZEB1. Oncotarget, 9(45), 27708-27727.
DOI Scopus20 Europe PMC18 |
| 2012 |
Hill, D., Eastaff-Leung, N., Bresatz-Atkins, S., Warner, N., Ruitenberg, J., Krumbiegel, D., . . . Barry, S. (2012). Inhibition of activation induced CD154 on CD4⁺ CD25⁻ cells: a valid surrogate for human Treg suppressor function. Immunology and Cell Biology, 90(8), 812-821.
DOI Scopus13 WoS11 Europe PMC10 |
| 2012 |
McInnes, N., Sadlon, T., Brown, C., Pederson, S., Beyer, M., Schultze, J., . . . Barry, S. (2012). FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells. Oncogene, 31(8), 1045-1054.
DOI Scopus93 WoS85 Europe PMC75 |
| 2010 |
Brown, C., Sadlon, T., Gargett, T., Melville, E., Zhang, R., Drabsch, Y., . . . Barry, S. (2010). Robust, reversible gene knockdown using a single lentiviral short hairpin RNA vector. Human Gene Therapy, 21(8), 1005-1017.
DOI Scopus27 WoS28 Europe PMC24 |
| 2010 |
Sadlon, T., Wilkinson, B., Pederson, S., Brown, C., Bresatz, S., Gargett, T., . . . Barry, S. (2010). Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. Journal of Immunology, 185(2), 1071-1081.
DOI Scopus124 WoS122 Europe PMC112 |
| 2009 |
Hutton, J., Gargett, T., Sadlon, T., Bresatz, S., Brown, C., Zola, H., . . . Barry, S. (2009). Development of CD4⁺CD25⁺FoxP3⁺ regulatory T cells from cord blood hematopoietic progenitor cells. Journal of Leukocyte Biology, 85(3), 445-451.
DOI Scopus29 WoS20 Europe PMC21 |
| 2002 |
Putland, R., Sassinis, T., Harvey, J., Diamond, P., Coles, L., Brown, C., & Goodall, G. (2002). RNA destabilization by the granulocyte colony-stimulating factor stem-loop destabilizing element involves a single stem-loop that promotes deadenylation. Molecular and Cellular Biology, 22(6), 1664-1673.
DOI Scopus35 WoS33 Europe PMC30 |
| 1999 |
Brown, C. Y., Mize, G. J., Pineda, M., George, D. L., & Morris, D. R. (1999). Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene, 18(41), 5631-5637.
DOI Scopus95 Europe PMC81 |
| 1996 |
Brown, C. Y., Lagnado, C. A., & Goodall, G. J. (1996). A cytokine mRNA-destabilizing element that is structurally and functionally distinct from A+U-rich elements. Proceedings of the National Academy of Sciences of the United States of America, 93(24), 13721-13725.
DOI Scopus65 WoS66 Europe PMC55 |
| 1996 |
Brown, C. Y., Lagnado, C. A., Vadas, M. A., & Goodall, G. J. (1996). Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. Journal of Biological Chemistry, 271(33), 20108-20112.
DOI Scopus90 WoS86 Europe PMC66 |
| 1994 |
Lagnado, C. A., Brown, C. Y., & Goodall, G. J. (1994). AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A). Molecular and Cellular Biology, 14(12), 7984-7995.
DOI Scopus320 WoS323 Europe PMC246 |
